Imad Shureiqi, MD

Imad Shureiqi, MD

Specialty: Medical Oncology
Title: Professor
4.9/5
See All Ratings

Accepts most insurance plans

To request an appointment call

734-647-8902
Imad Shureiqi, MD
Imad Shureiqi, MD
Medical Oncology
  • Expertise
  • Locations
  • Insurance
  • Education & Training
  • Patient Ratings & Comments
  • Manage Your Profile

  • Expertise

    Locations

    • Oncology Clinic | Rogel Cancer Center 1500 E Medical Center Dr
      Floor B1 Reception E
      Ann Arbor, MI 48109-5912
      Get Directions

    Insurance Accepted

    University of Michigan Health participates with most health insurance plans.

    See our insurance details

    Education & Training

    Medical School or Training

    Damascus University Medical School, 1985

    Residency

    Erie County Medical Center, Internal Medicine, 1991

    Fellowships

    University of Michigan Health System, Internal Medicine Hematology Oncology, 1997
    Erie County Medical Center, Hematology, 1992

    Board Certifications

    Medical Oncology

    Patient Ratings & Comments

    Visit our Physician Ratings & Comments page to learn more about how patient ratings are collected, calculated, and updated to help you make an informed decision when choosing the right physician for your care.

    Patient Ratings

    88 Patient Ratings

    Patient Comments

    June 12, 2026 - "Dr Shureiqi is an excellent physician cares for his patients"

    April 11, 2026 - "Dr. Shureiqi asks insightful questions, listens attentively, and proposes viable options which allow me to be an active participant in my care."

    April 9, 2026 - "Dr. Shureiqi is the best, and I'm very fortunate to have him as my oncologist."

    September 14, 2025 - "Dr. Shureiqi is an excellent physician. He is a great asset to the Michigan health system. We value his competence and his kindness."

    Featured News & Stories

    yellow background green bottle with purple hand says DHA and question marks
    Health Lab

    Fish oil supplements may not work for certain cancer patients

    Michigan Medicine study emphasizes the need to screen for the presence of ALOX15 in cancer patients when developing prevention strategies using fish oil supplements.